FAM13A polymorphism is associated with a usual interstitial pneumonia pattern in patients with systemic sclerosis-associated interstitial lung disease

被引:0
作者
Bernstein, Elana J. [1 ]
Boin, Francesco [2 ]
Elicker, Brett [3 ]
Luo, Yiming [1 ]
Ren, Yawen [4 ]
Zhang, Meng [5 ]
Varga, John [6 ]
Assassi, Shervin [5 ]
机构
[1] Columbia Univ, Irving Med Ctr, Vagelos Coll Phys & Surg, Dept Med,Div Rheumatol, New York, NY USA
[2] Cedars Sinai Med Ctr, Dept Med, Div Rheumatol, Los Angeles, CA USA
[3] Univ Calif San Francisco, Dept Radiol, San Francisco, CA USA
[4] Univ Colorado, Dept Med, Div Rheumatol, Denver, CO USA
[5] Univ Texas Hlth Sci Ctr Houston, UTHlth Houston, Dept Med, Div Rheumatol, Houston, TX USA
[6] Univ Michigan, Dept Internal Med, Div Rheumatol, Ann Arbor, MI USA
基金
美国国家卫生研究院;
关键词
systemic sclerosis; interstitial lung disease; usual interstitial pneumonia; FAM13A; MUC5B; IDIOPATHIC PULMONARY-FIBROSIS; PROMOTER POLYMORPHISM; SUSCEPTIBILITY; GENE; SCLERODERMA; LOCI;
D O I
10.1093/rheumatology/keae573
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: The MUC58 promoter single nucleotide polymorphism (SNP) rs35705950 has been associated with idiopathic pulmonary fibrosis (IPF) and RA-related interstitial lung disease (ILD), but not with SSc-ILD. We hypothesized that the MUC58 promoter polymorphism or other IPF susceptibility loci are associated with an increased risk for the uncommon SSc-usual interstitial pneumonia (UIP) endophenotype, rather than SSc-ILD in general. Methods: We performed a cross-sectional study of SSc-ILD patients from four US Scleroderma Programs to investigate the frequency of MUC58 rs35705950 and 12 additional IPF susceptibility loci. SSc-ILD patients were stratified by high resolution chest CT (HRCT) imaging findings into UIP and non-UIP groups. Analysis of HRCTs performed by a thoracic radiologist blinded to participants' characteristics classified each scan as definite UIP, probable UIP, indeterminate or alternative diagnosis, according to American Thoracic Society criteria. Results: Four-hundred and eighty-nine SSc-ILD patients were included; 80% were female and 75% were White. Twenty-three (4.7%) patients had a definite UIP pattern. The MUC58 SNP rs35705950 was not associated with a definite UIP pattern in SSc-ILD. In contrast, patients carrying two copies of the IPF risk gene FAM13A minor allele rs2609255 had significantly higher odds of a definite UIP pattern compared with the other patterns (odds ratio 3.40, 95% CI 1.19-9.70), and compared with an alternative diagnosis (odds ratio 3.65, 95% CI 1.25-10.65). Conclusion: We demonstrated a novel association between FAM13A and SSc-UIP. Contrary to IPF and RA-ILD, the MUC58 promoter polymorphism was not associated with a definite UIP pattern in SSc-ILD.
引用
收藏
页数:6
相关论文
共 50 条
  • [11] Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung disease
    Bergamasco, Aurore
    Hartmann, Nadine
    Wallace, Laura
    Verpillat, Patrice
    CLINICAL EPIDEMIOLOGY, 2019, 11 : 257 - 273
  • [12] Therapeutic effects of thalidomide on patients with systemic sclerosis-associated interstitial lung disease
    Pan, Jie
    Dong, Fei
    Ma, Li
    Zhao, Cheng
    Qin, Fang
    Wen, Jing
    Wei, Wanling
    Lei, Ling
    JOURNAL OF SCLERODERMA AND RELATED DISORDERS, 2023, 8 (03) : 231 - 240
  • [13] Systemic sclerosis-associated interstitial lung disease: Role of the oesophagus in outcomes
    Strek, Mary E.
    RESPIROLOGY, 2018, 23 (10) : 885 - 886
  • [14] Severity and features of frailty in systemic sclerosis-associated interstitial lung disease
    Guler, Sabina A.
    Kwan, Joanne M.
    Winstone, Tiffany A.
    Milne, Kathryn M.
    Dunne, James V.
    Wilcox, Pearce G.
    Ryerson, Christopher J.
    RESPIRATORY MEDICINE, 2017, 129 : 1 - 7
  • [15] Mycophenolate mofetil in systemic sclerosis-associated interstitial lung disease
    Koutroumpas, Athanasios
    Ziogas, Athanasios
    Alexiou, Ioannis
    Barouta, Georgia
    Sakkas, Lazaros I.
    CLINICAL RHEUMATOLOGY, 2010, 29 (10) : 1167 - 1168
  • [16] Mycophenolate mofetil in systemic sclerosis-associated interstitial lung disease
    Athanasios Koutroumpas
    Athanasios Ziogas
    Ioannis Alexiou
    Georgia Barouta
    Lazaros I. Sakkas
    Clinical Rheumatology, 2010, 29 : 1167 - 1168
  • [17] Deep-learning CT imaging algorithm to detect usual interstitial pneumonia pattern in patients with systemic sclerosis-associated interstitial lung disease: association with disease progression and survival
    Stock, Carmel J. W.
    Nan, Yang
    Fang, Yingying
    Kokosi, Maria
    Kouranos, Vasilios
    George, Peter M.
    Chua, Felix
    Jenkins, Gisli R.
    Devaraj, Anand
    Desai, Sujal R.
    Denton, Christopher P.
    Wells, Athol U.
    Walsh, Simon L. F.
    Renzoni, Elisabetta A.
    RHEUMATOLOGY, 2024,
  • [18] Oesophageal diameter is associated with severity but not progression of systemic sclerosis-associated interstitial lung disease
    Winstone, Tiffany A.
    Hague, Cameron J.
    Soon, Jeanette
    Sulaiman, Nada
    Murphy, Darra
    Leipsic, Jonathon
    Dunne, James V.
    Wilcox, Pearce G.
    Ryerson, Christopher J.
    RESPIROLOGY, 2018, 23 (10) : 921 - 926
  • [19] Pleuroparenchymal fibroelastosis in systemic sclerosis-associated interstitial lung disease
    Sari, Alper
    Onder, Omer
    Armagan, Berkan
    Bolek, Ertugrul Cagri
    Farisogullari, Bayram
    Bilgin, Emre
    Yardimci, Gozde Kubra
    Ariyurek, Macit
    Akdogan, Ali
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2022, 52 (01) : 83 - 88
  • [20] Tomographic Fibrosis Score in the Patients with Systemic Sclerosis-Associated Interstitial Lung Disease
    Ozmen, Mustafa
    Gumus, Cesur
    Otman, Eda
    Sinci, Kazim Ayberk
    Aysin, Idil Kurut
    Solmaz, Dilek
    Akar, Servet
    EUROPEAN JOURNAL OF RHEUMATOLOGY, 2023, 10 (03) : 107 - 113